Ukrainian healthcare is evolving continuously, with majorly a consumer-centric approach from the regulators. With the forthcoming healthcare reforms and with accession of Ukrain to WTO is expected to bring in radical changes in the healthcare scenario. Though the pain-staking efforts and committed attempts, Genome has become a trustworthy BRAND in Ukrain. Genom Biotech Pvt Ltd represents Genom (India) in Ukrain.
Over the last decade Genom Biotech has strategically aligned its resources and activities to suit its commitment for Health for Everyone. In Ukrain, Genom has more than 100 products registered and more in the approval phase. Genom has consolidate its position with several registered offices across regions and 34 medical representatives catering to clinical, primary health centers and hospitals, all the time. Cooperation with leading Ukrainian distributors and with effectively working regional wholesale companies allows to carry out fast and qualitative delivery both known, and new products in all regions of Ukraine. The majority of consumers of our products are people with the low income. Taking into account financial position of some categories of the population, we pay big attention in rendering charitable help to patients of central regional hospitals. We work for people and try to help them according our capability, promoting availability of qualitative treatment.
Our most appreciated products include COLDFLU, SIGAN, TRISILS lozenges , GENAGRA, COFEX, combined fermental preparation ENZYMTAL, AMLO, ENAPRIL-H, BRONCHORYL, the complex ferriferous preparation including vitamins and microcells, GLOBIGEN, PYRANTEL, ZESTRA, ATENOL-H, LANZA, CARDITAL, AZINOM, METROZOL, CIPROTIN, ROXIN, CIPRONAT, PERILIUM and APROKAL. Genom is penetrating deep into market with the new & innovative products every year. |
